Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -3.56% vs 13.66% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 16.57% vs 49.88% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8,140.60",
          "val2": "8,441.30",
          "chgp": "-3.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,495.90",
          "val2": "2,353.60",
          "chgp": "6.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.40",
          "val2": "2.00",
          "chgp": "-80.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "129.10",
          "val2": "75.80",
          "chgp": "70.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,281.00",
          "val2": "1,956.80",
          "chgp": "16.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "306.60%",
          "val2": "250.30%",
          "chgp": "5.63%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 13.11% vs 22.70% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 21.78% vs 48.14% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "31,431.00",
          "val2": "27,787.80",
          "chgp": "13.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8,961.00",
          "val2": "7,271.20",
          "chgp": "23.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "15.10",
          "val2": "6.50",
          "chgp": "132.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "173.60",
          "val2": "108.60",
          "chgp": "59.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7,717.00",
          "val2": "6,337.00",
          "chgp": "21.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "255.10%",
          "val2": "230.30%",
          "chgp": "2.48%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

8,140.60

8,441.30

-3.56%

Operating Profit (PBDIT) excl Other Income

2,495.90

2,353.60

6.05%

Interest

0.40

2.00

-80.00%

Exceptional Items

129.10

75.80

70.32%

Consolidate Net Profit

2,281.00

1,956.80

16.57%

Operating Profit Margin (Excl OI)

306.60%

250.30%

5.63%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -3.56% vs 13.66% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 16.57% vs 49.88% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

31,431.00

27,787.80

13.11%

Operating Profit (PBDIT) excl Other Income

8,961.00

7,271.20

23.24%

Interest

15.10

6.50

132.31%

Exceptional Items

173.60

108.60

59.85%

Consolidate Net Profit

7,717.00

6,337.00

21.78%

Operating Profit Margin (Excl OI)

255.10%

230.30%

2.48%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 13.11% vs 22.70% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 21.78% vs 48.14% in Dec 2024

All Annual Results